CEO Paywatch: General Mills' Ken Powell made $14.3 million last fiscal year

August 18, 2016 at 1:45AM
Portrait of Ken Powell, General Mills CEO Wednesday December 2, 2015 in Golden Valley , MN.] . Jerry Holt /Jerry.Holt@Startribune.com
General Mills CEO Ken Powell received total compensation of $14,302,884 for the year that ended May 31, 2016. (The Minnesota Star Tribune)
Ken Powell
General Mills Inc. chairman, CEO

Total compensation: $14,302,884 for the year ended May 31, 2016

Salary: $1,206,500

Nonequity incentive pay: $2,258,568

Other compensation: $187,903

Exercised stock options: $5,540,625

Value realized on vesting shares: $5,109,288

New stock options: 248,107

Total fiscal 2016 shareholder return: 15.3 percent

Note: Powell has been CEO of the Golden Valley-based food company since September 2007. Much of his $14.3 million in compensation was from previously issued long-term equity awards, including options he exercised during the year and restricted stock that vested.

The company largely met or exceeded its annual performance goals for organic sales growth, profitability and capital improvement after it accounted for a number of strategic acquisitions and dispositions, including the $765 million sale of the North American Green Giant vegetable business in September.

As a result, Powell and other executives earned a greater-than-targeted annual bonus. Powell's bonus for the year of $2.3 million was a 34-percent increase over the previous year.

about the writer

about the writer

Patrick Kennedy

Reporter

Business reporter Patrick Kennedy covers executive compensation and public companies. He has reported on the Minnesota business community for more than 25 years.

See Moreicon

More from Business

See More
card image
Fairview Health Services

The school is changing an elective course while still working with the Eden Prairie-based health care giant after students raised concerns.

This transmission electron microscope image shows SARS-CoV-2, the virus that causes COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in the lab. (NIAID/TNS) ORG XMIT: 1659810
card image